Source:http://linkedlifedata.com/resource/pubmed/id/15577606
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2004-12-3
|
pubmed:abstractText |
Defined autoantibodies are found in about half of the patients with myositis. Traditionally, these autoantibodies have been divided into myositis specific autoantibodies (MSAs) and myositis associated autoantibodies. Several studies have shown that MSAs are associated with specific clinical characteristics and can aid our understanding of the pathophysiology of myositis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1040-8711
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
692-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading | |
pubmed:year |
2004
|
pubmed:articleTitle |
Myositis specific autoantibodies: changing insights in pathophysiology and clinical associations.
|
pubmed:affiliation |
Neuromuscular Centre Nijmegen, Department of Neurology, University Medical Centre Nijmegen, Internal mail number 326, PO Box 9101, 6500 HB Nijmegen, The Netherlands. g.hengstman@neuro.umcn.nl
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|